Future Oncology, Volume 11, Issue 1 (2015)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Future Oncology, Volume 11, Issue 1 (2015)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Volume 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Editorial

Editorial
Exceptional Responders: in Search of the Science Behind the Miracle Cancer Cures
Ishwaria Mohan Subbiah & Vivek Subbiah
Pages: 1-4
Published online: 09 Jan 2015
First Page PreviewforExceptional Responders: in Search of the Science Behind the Miracle Cancer Cures | Full Text | References | PDF (1.9 MB)
  • 1405 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Editorial
What is the Future for Cancer Clinical Trials?
Francesco Perrone
Pages: 5-7
Published online: 09 Jan 2015
First Page PreviewforWhat is the Future for Cancer Clinical Trials? | Full Text | References | PDF (1.6 MB)
  • 88 Views
  • 0 CrossRef citations
  • 0Altmetric
Editorial
Breakthrough Targeted Therapeutic Approaches to Squamous Cell Carcinoma of the Head and Neck
Alberto Mangano, Alessandro Mangano, Georgios D Lianos, Dimitrios H Roukos, Alberto Caprioglio & Gianlorenzo Dionigi
Pages: 9-12
Published online: 09 Jan 2015
First Page PreviewforBreakthrough Targeted Therapeutic Approaches to Squamous Cell Carcinoma of the Head and Neck | Full Text | References | PDF (1.6 MB)
  • 63 Views
  • 0 CrossRef citations
  • 0Altmetric

Commentary

Editorial
Pertuzumab-Induced Cardiotoxicity: Safety Compared with Trastuzumab
Mehmet A. N. Sendur, Sercan Aksoy & Kadri Altundag
Pages: 13-15
Published online: 09 Jan 2015
First Page PreviewforPertuzumab-Induced Cardiotoxicity: Safety Compared with Trastuzumab | Full Text | References | PDF (1.9 MB)
  • 310 Views
  • 0 CrossRef citations
  • 0Altmetric

Case Series

Case Report
Development of Chronic Myeloid Leukaemia in Patients Treated with Anti-VEGF Therapies for Clear Cell Renal Cell Cancer
Anna M Czarnecka, Sylwia Oborska, Piotr Rzepecki & Cezary Szczylik
Pages: 17-26
Published online: 23 Jun 2014
AbstractforDevelopment of Chronic Myeloid Leukaemia in Patients Treated with Anti-VEGF Therapies for Clear Cell Renal Cell Cancer | Full Text | References | PDF (1.8 MB)
  • 1416 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Drug Evaluation

Review Article
Ipilimumab in the Treatment of Prostate Cancer
Zachary Reese, Ali Straubhar, Sumanta K Pal & Neeraj Agarwal
Pages: 27-37
Published online: 09 Jan 2015
AbstractforIpilimumab in the Treatment of Prostate Cancer | Full Text | References | PDF (2 MB)
  • 217 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Dovitinib (CHIR258, TKI258): Structure, Development and Preclinical and Clinical Activity
Camillo Porta, Palma Giglione, Wanda Liguigli & Chiara Paglino
Pages: 39-50
Published online: 09 Jan 2015
AbstractforDovitinib (CHIR258, TKI258): Structure, Development and Preclinical and Clinical Activity | Full Text | References | PDF (2.1 MB)
  • 277 Views
  • 0 CrossRef citations
  • 0Altmetric

Clinical Trial Protocol

Review Article
The HELIOS Trial Protocol: A Phase III Study of Ibrutinib in Combination with Bendamustine and Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia
Michael Hallek, Neil E Kay, Anders Osterborg, Asher A Chanan-Khan, Michelle Mahler, Mariya Salman, Ying Wan, Steven Sun, Sen Hong Zhuang & Angela Howes
Pages: 51-59
Published online: 05 Jun 2014
AbstractforThe HELIOS Trial Protocol: A Phase III Study of Ibrutinib in Combination with Bendamustine and Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia | Full Text | References | PDF (1.8 MB)
  • 7339 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Research Article

Article
Neoadjuvant Breast Cancer Treatment as a Sensitive Setting for Trastuzumab Biosimilar Development and Extrapolation
Christian Jackisch, Frank A Scappaticci, Dominik Heinzmann, Fabio Bisordi, Thomas Schreitmüller, Gunter von Minckwitz & Javier Cortés
Pages: 61-71
Published online: 28 Aug 2014
AbstractforNeoadjuvant Breast Cancer Treatment as a Sensitive Setting for Trastuzumab Biosimilar Development and Extrapolation | Full Text | References | PDF (1.9 MB)
  • 4392 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Busting Robustness: Using Cancer’s Greatest Strength to Our Advantage
Jason R Westin
Pages: 73-77
Published online: 27 Mar 2014
AbstractforBusting Robustness: Using Cancer’s Greatest Strength to Our Advantage | Full Text | References | PDF (2.4 MB)
  • 241 Views
  • 0 CrossRef citations
  • 0Altmetric

Systematic Review

Review Article
Risk of Fatigue and Hepatic and Metabolic Toxicities in Patients with Solid Tumors Treated with Everolimus: A Meta-Analysis
Omar Abdel-Rahman & Mona Fouad
Pages: 79-90
Published online: 09 Jan 2015
AbstractforRisk of Fatigue and Hepatic and Metabolic Toxicities in Patients with Solid Tumors Treated with Everolimus: A Meta-Analysis | Full Text | References | PDF (1.9 MB)
  • 163 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Metastatic Castration-Resistant Prostate Cancer: Time for Innovation
Marcello Tucci, Giorgio Vittorio Scagliotti & Francesca Vignani
Pages: 91-106
Published online: 09 Jan 2015
AbstractforMetastatic Castration-Resistant Prostate Cancer: Time for Innovation | Full Text | References | PDF (1.8 MB)
  • 417 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Prognostic and Predictive Factors in Patients Treated with Chemotherapy for Advanced Urothelial Cancer: Where Do We Stand?
Sebastiano Buti, Chiara Ciccarese, Daniele Zanoni, Matteo Santoni, Alessandra Modena, Francesca Maines, Annalisa Gilli, Emilio Bria, Matteo Brunelli, Anita Rimanti, Stefano Cascinu, Andrea Ardizzoni, Giampaolo Tortora & Francesco Massari
Pages: 107-119
Published online: 09 Jan 2015
AbstractforPrognostic and Predictive Factors in Patients Treated with Chemotherapy for Advanced Urothelial Cancer: Where Do We Stand? | Full Text | References | PDF (1.8 MB)
  • 168 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Pathology, Therapy and Prognosis of Papillary Renal Carcinoma
Diana Silva Fernandes & José Manuel Lopes
Pages: 121-132
Published online: 09 Jan 2015
AbstractforPathology, Therapy and Prognosis of Papillary Renal Carcinoma | Full Text | References | PDF (2.2 MB)
  • 233 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Pembrolizumab Joins the Anti-PD-1 Armamentarium in the Treatment of Melanoma
Peter Hersey & Kavitha Gowrishankar
Pages: 133-140
Published online: 09 Jan 2015
AbstractforPembrolizumab Joins the Anti-PD-1 Armamentarium in the Treatment of Melanoma | Full Text | References | PDF (1.7 MB)
  • 552 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
The Role of miRNAs in Bone Metastasis and their Significance in the Detection of Bone Metastasis: A Review of the Published Data
Qian Huang & Xuenong Ouyang
Pages: 141-151
Published online: 09 Jan 2015
AbstractforThe Role of miRNAs in Bone Metastasis and their Significance in the Detection of Bone Metastasis: A Review of the Published Data | Full Text | References | PDF (1.7 MB)
  • 144 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
What is the Best Strategy for Targeting EGF Receptors in Non-Small-Cell Lung Cancer?
Robert Pirker
Pages: 153-167
Published online: 09 Jan 2015
AbstractforWhat is the Best Strategy for Targeting EGF Receptors in Non-Small-Cell Lung Cancer? | Full Text | References | PDF (1.8 MB)
  • 205 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Pericytes: A Double-Edged Sword in Cancer Therapy
Mao-Bin Meng, Nicholas G Zaorsky, Lei Deng, Huan-Huan Wang, Jiang Chao, Lu-Jun Zhao, Zhi-Yong Yuan & Wang Ping
Pages: 169-179
Published online: 21 Aug 2014
AbstractforPericytes: A Double-Edged Sword in Cancer Therapy | Full Text | References | PDF (2.6 MB)
  • 659 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

STELLAR-303: randomized phase III study of zanzalintinib + atezolizumab in previously treated metastatic colorectal cancer
Anwaar Saeed et al.
Method | Published online: 23 Jul 2024
Gastric cancer in pregnancy: a review
Hongming Liu et al.
Review Article | Published online: 23 Jul 2024
A novel prognostic index for extranodal natural killer/T-cell lymphoma in the era of pegaspargase/L-asparaginase
Ziyuan Shen et al.
Article | Published online: 23 Jul 2024
An investigator-initiated clinical study in patients with refractory or recurrent solid tumors: ‘R-ISV-FOLactis’ trial
Juanjuan Dai et al.
Method | Published online: 21 Jul 2024
View all latest articles